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Abstract
Staphylococcus aureus is the predominant cause of bacteremia worldwide. We assessed the 
molecular epidemiology and antibiotic resistance of MRSA isolates causing bacteremia in 
Southern Mississippi. Diverse genetic backgrounds in terms of SCCmec, PFGE, and MLST types 
of MRSA were identified as causing bacteremia in Mississippi. A strong association of Panton – 
Valentine Leukocidin (PVL) genes with elevated vancomycin MIC is one of the important 
findings of our study.
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Background
Staphylococcus aureus is a major human pathogen responsible for both community and 
healthcare-associated infections. In the United States, pulsed field type USA300 has been 
the dominant strain causing methicillin resistant Staphylococcus aureus (MRSA) infections 
in community settings. Although USA100 used to be the predominant type causing clinical 
bacteremia, some reported that USA300 is becoming more dominant even in healthcare 
settings [1]. Notably, in that study, no data was reported from Mississippi. This gap in the 
epidemiological information led to this study.
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Vancomycin has been the most successful antibiotic against MRSA infections. However, 
continued use of vancomycin leads to emergence of resistance [2–5]. Hence, for effective 
treatment with vancomycin, early detection of risk factors that may be associated with the 
increased resistance is important.
We genotyped 30 randomly chosen bacteremia-causing isolates by molecular methods, 
assessed their antibiotic resistance, and analyzed the association of risk factors with the 
elevated vancomycin MIC in certain strains.
Methods
The Institutional Review Board of The University of Southern Mississippi and the Forrest 
General Hospital approved this study. Between March 2013 and February 2014, 322 MRSA 
isolates were collected from a large hospital in Southern Mississippi. From these, 30 blood 
isolates were randomly selected for this study.
The presence of mecA, Panton – Valentine leukocidin genes (PVL) and hemolysin gamma 
(hlg) were tested by PCR using chromosomal DNA prepared from the isolates. Pulsed field 
gel electrophoresis (PFGE), Multi-locus sequence typing (MLST), and SCCmec typings 
were performed as described elsewhere [6–8].
Isolates were tested for susceptibility to vancomycin, oxacillin, erythromycin, clindamycin, 
rifampin, amoxicillin-clavulanic acid, trimethoprim-sulfamethoxazole, and linezolid using 
the broth microdilution method [9]. The medical records of all the patients were reviewed 
for potential risk factors. These factors were binary coded in SPSS. The association between 
risk factors and vancomycin MIC >1 µg/ml was analyzed by Fisher’s exact test. The factors 
that displayed a P value < 0.2 were included in logistic regression to determine the odds 
ratio (OR).
Results
The MRSA isolates belonged to two major clusters in PFGE, designated A and B (Figure 1). 
Cluster A was composed of isolates with USA100 and USA800 types, whereas Cluster B 
was composed of USA300 and USA700 type isolates. USA300 was found to be the most 
common (40%). USA100, 700 and 800 accounted for 23.3, 20 and 13.3% of the isolates 
respectively. 40% of the isolates belonged to ST5, constituting the largest group. ST8, ST72 
and ST100 were found in 37, 20 and 3% of the isolates respectively. SCCmec type IV was 
found in 67% of the isolates. All but one of the USA300 isolates were mec type IV. USA100 
isolates were found to exclusively possess SCCmec type II, which accounted for 29% of the 
blood isolates.
All USA300 strains were found to be PVL positive. USA100 strains were mostly found to 
be PVL negative, indicating HA-MRSA isolates (17%). All isolates were resistant to 
oxacillin and amoxicillin-clavulanic acid. 93% were resistant to erythromycin followed by 
30% resistant to clindamycin. All isolates were sensitive to vancomycin, rifampin, 
trimethoprim-sulfamethoxazole, and linezolid. Notably, we observed that some isolates had 
MIC for vancomycin higher than others. Specifically, 10 isolates had vancomycin MIC >1 
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µg/ml and of them, five isolates had MIC of 2 µg/ml (Table 1). We aimed to identify any 
risk factors associated with this phenomenon. Review of the medical records of the patients 
revealed several potential risk factors (Table 2). A univariate analysis revealed that smoking 
(P = 0.09), prior antibiotic use (P = 0.03), Prior hospitalization (P = 0.1), coming from a 
nursing home (P = 0.07), and presence of PVL in the isolate (P =0.01) may be associated 
with vancomycin MIC >1 µg/ml. These factors were then included in logistic regression to 
determine the OR. The results are summarized in Table 2. Interestingly, presence of PVL 
showed OR of 12.223, 95% confidence interval 1.507 – 32.769; P = 0.024. This suggests 
that the odds of elevated vancomycin MIC increase with presence of PVL genes in the 
isolate.
Discussion
Our analysis showed that the majority of bacteremia were caused by USA300-ST8-
SCCmecIV isolates. This predominance of USA300 was observed in studies done in other 
regions of the United States as well. The predominance of CA-MRSA over HA-MRSA in 
the hospital setting has been mathematically modeled by D’Agata et al. [10]. They predicted 
that CA-MRSA would eventually become dominant in hospitals. Our observation from the 
hospitalized patients confirms the predominance of USA300 isolates (CA-MRSA) in 
bacteremia-causing isolates in our region.
USA300 isolates are typically susceptible to clindamycin [6]. However, in this study, we 
found that 30% of USA300 isolates were clindamycin resistant. This supports previous 
observations in other studies that reported emerging resistance of USA300 isolates against 
clindamycin [11–14].
An important finding of our study is the strong association of the PVL genes with elevated 
vancomycin MIC. PVL is a leukocidin that kills human neutrophils by lysing the cell 
membrane. Although it is regarded as a virulence factor for CA-MRSA isolates, the role of 
PVL has been debated [15–19]. Any relation between PVL and vancomycin MIC has not 
been studied and further research is needed. Our study suggests that an early detection of 
PVL in an isolate may be important to make decisions about subjecting a patient to 
prolonged vancomycin treatment so that emergence of any vancomycin intermediate isolate 
can be prevented.
Identification of the factor ‘coming from a nursing home’ associated with elevated 
vancomycin MIC, suggest that some of these patients may have been colonized with MSRA 
during their stay in healthcare facilities. Nursing home and their staff have been described as 
reservoirs for MRSA and they are likely to share the same MRSA strain [20]. Thus, strict 
infection control measures are needed to stop the spread of MRSA to the residents and 
workers in nursing homes. MRSA in nursing homes can be under control by enhancing 
infection prevention measures such as early screening and decolonization of MRSA carriers, 
improving hand hygiene, and decreasing the resident:staff ratio [21]
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As most of the MRSA in this study were USA300 or community-associated MRSA, a 
particular area where interventions would be valuable from the public health perspective is 
to develop effective strategies for preventing infections outside the acute care setting.
In conclusion, to the best of our knowledge, this is the first report of systematic analysis of 
MRSA isolates in Mississippi. Collectively our data show the presence of both CA-MRSA 
and HA-MRSA isolates among bacteremia-causing MRSA in this region and that USA300 
is dominant in a hospital setting, which is also an extension of a nationwide observation and 
mathematical prediction; however, the association of PVL genes as a risk for vancomycin 
MIC warrants more detailed investigation.
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• USA300 (SCCmec IV) is predominant in Southern Mississippi
• Emerging clindamycin resistance has been observed in 30% of the USA300 
isolates
• Elevated vancomycin MIC (>1 µg/ml) has been observed in some isolates
• Presence of PVL was found to be a potential risk factor to elevated vancomycin 
MIC
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Pulsed-field gel electrophoresis of Blood-MRSA isolates shows that, using an 80% 
similarity cutoff, the isolates can be grouped into two major clusters. The cluster A is 
composed of USA100 and USA800 isolates whereas the cluster B is consisting USA300 and 
USA700 isolates. One of the isolates (USMFG160) was found to be novel in PFGE analysis, 
however because of its closeness to USA800 isolates, it was kept in cluster A.
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Table 1
Number of isolates possessing different MIC for vancomycin
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Table 2
Regression analysis between vancomycin MIC > 1 µg/ml and potential risk factors#
Variables Odds Ratio 95% Confidence
interval of Odds ratio
P
PVL genes 12.223 1.507 – 32.769 0.024
History of Smoking 0.007 0.000 – 0.220 0.005
Prior antibiotic use 1.160 0.009 – 2.560 0.104
Prior hospitalized 1.611 0.123 – 21.122 0.717
Coming from a nursing home 2.230 0.065 – 16.500 0.657
#
Upon reviewing patients’ medical records, we identified following potential risk factors: age, sex, weight, service in first 48 hours, diabetes 
mellitus, chronic kidney disease, chronic heart failure, obesity, BMI, Immunosuppression, mechanical ventilation, HIV, use of injection drugs, 
smoking, prior antibiotic use, prior hospitalization, prior surgery, have been to long term care facility, dialysis, intravenous catheter, coming from a 
nursing home, positive MRSA culture, positive nasal swab, presence of PVL genes, presence of hlg gene, isolates’ SCCmec type, isolates’ pulsed 
field type, and isolates’ MLST type. For crude analysis of association of these factors with vancomycin MIC > 1µg/ml, we performed a Fisher’s 
exact test. The factors that showed a P value lower than 0.2, such as presence of PVL (P = 0.01), smoking (P = 0.09), prior antibiotic use (P = 
0.03), prior hospitalization (P = 0.1), and coming from a nursing home (P = 0.07) were included in the binary logistic regression analysis to 
determine the odds ratio.
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